ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: A2MR; APOER; Alpha-2-macroglobulin receptor; Apolipoprotein E receptor; CD91; LRP-1 85 kDa subunit; Prolow-density lipoprotein receptor-related protein 1
Storage: 2-8C
Application: Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected LRP1 85 kDa subunit in HEK293 cell lysate.Flow Cytometry Analysis: 1 mug from a representative lot detected LRP1 85kDa subunit in one million HEK293 cells.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected LRP1 85kDa subunit in C6, PC12, C2C12, SH-SY5Y cells.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany